Global Preventive Medicine for Pets Market Growth 2025-2031
Description
The global Preventive Medicine for Pets market size is predicted to grow from US$ 1122 million in 2025 to US$ 1810 million in 2031; it is expected to grow at a CAGR of 8.3% from 2025 to 2031.
Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 50%.
LP Information, Inc. (LPI) ' newest research report, the “Preventive Medicine for Pets Industry Forecast” looks at past sales and reviews total world Preventive Medicine for Pets sales in 2024, providing a comprehensive analysis by region and market sector of projected Preventive Medicine for Pets sales for 2025 through 2031. With Preventive Medicine for Pets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preventive Medicine for Pets industry.
This Insight Report provides a comprehensive analysis of the global Preventive Medicine for Pets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preventive Medicine for Pets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preventive Medicine for Pets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preventive Medicine for Pets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preventive Medicine for Pets.
This report presents a comprehensive overview, market shares, and growth opportunities of Preventive Medicine for Pets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Powder
Liquid
Segmentation by Application:
Cat
Dog
Reptile
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan chopperlvya
CAHIC
Key Questions Addressed in this Report
What is the 10-year outlook for the global Preventive Medicine for Pets market?
What factors are driving Preventive Medicine for Pets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Preventive Medicine for Pets market opportunities vary by end market size?
How does Preventive Medicine for Pets break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 50%.
LP Information, Inc. (LPI) ' newest research report, the “Preventive Medicine for Pets Industry Forecast” looks at past sales and reviews total world Preventive Medicine for Pets sales in 2024, providing a comprehensive analysis by region and market sector of projected Preventive Medicine for Pets sales for 2025 through 2031. With Preventive Medicine for Pets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preventive Medicine for Pets industry.
This Insight Report provides a comprehensive analysis of the global Preventive Medicine for Pets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preventive Medicine for Pets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preventive Medicine for Pets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preventive Medicine for Pets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preventive Medicine for Pets.
This report presents a comprehensive overview, market shares, and growth opportunities of Preventive Medicine for Pets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Powder
Liquid
Segmentation by Application:
Cat
Dog
Reptile
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan chopperlvya
CAHIC
Key Questions Addressed in this Report
What is the 10-year outlook for the global Preventive Medicine for Pets market?
What factors are driving Preventive Medicine for Pets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Preventive Medicine for Pets market opportunities vary by end market size?
How does Preventive Medicine for Pets break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
113 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Preventive Medicine for Pets by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Preventive Medicine for Pets by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
